scispace - formally typeset
M

Michael Karin

Researcher at University of California, San Diego

Publications -  753
Citations -  246120

Michael Karin is an academic researcher from University of California, San Diego. The author has contributed to research in topics: IκB kinase & Signal transduction. The author has an hindex of 236, co-authored 704 publications receiving 226485 citations. Previous affiliations of Michael Karin include Sanford-Burnham Institute for Medical Research & University of California, Los Angeles.

Papers
More filters
Journal Article

Inhibitor of Nuclear Factor κB Kinase Deficiency Enhances Oxidative Stress and Prolongs c-Jun NH2-Terminal Kinase Activation Induced by Arsenic

TL;DR: Increased CYP1B1 expression is central to and seems to be responsible for sensitizing Ikkbeta(-/-) cells to stress-induced JNK activation, which was largely associated with an oxidative stress response.
Journal ArticleDOI

Inhibition of IκB Kinase by a New Class of Retinoid-Related Anticancer Agents That Induce Apoptosis

TL;DR: It is found that retinoid antagonist MX781 inhibited the activation of NF-κB-dependent transcriptional activity in different tumor cell lines and induction of apoptosis by the Retinoid-related molecules that inhibited IKK was dependent on caspase activity but independent of the retinoids receptors.
Journal ArticleDOI

Induction of Metallothionein mRNA in HeLa Cells by Dexamethasone and by Heavy Metals

TL;DR: Increased synthesis and accumulation of metallothionein in response to either metal or glucocorticoid exposure is regulated by the level of translatable metallothsionein mRNA in HeLa cells.
Journal ArticleDOI

Choline kinase inhibition in rheumatoid arthritis

TL;DR: Data suggest that ChoKα inhibition could be an effective strategy in inflammatory arthritis and suggests that targeting the metabolome can be a new treatment strategy in non-cancer conditions.